Ricerca avanzata

Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5)

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5)

UPDATE ON THE DIAGNOSIS AND TREATMENT OF DIFFERENTIATED THYROID CANCER 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):440-53

Molecular pathology of differentiated thyroid cancer

Greco A., Borrello M. G., Miranda C., Degl’Innocenti D., Pierotti M. A.


UPDATE ON THE DIAGNOS AND TREATMENT OF DIFFERENTIATE THYROID CANCER 

 REVIEW

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):455-63

Potential value of elastosonography in the diagnosis of malignancy in thyroid nodules

Rago T., Vitti P.


UPDATE ON THE DIAGNOSIS AND TREATMENT OF DIFFERENTIATED THYROID CANCER 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 October;53(5):465-72

Update on the diagnosis and treatment of differentiated thyroid cancer

Miccoli P., Minuto M. N., Berti P., Materazzi G.


 REVIEW

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):473-81

Radioiodine ablation: when and how

Ambrosetti M. C., Colato C., Dardano A., Monzani F., Ferdeghini M.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):482-9

Serum thyroglobulin measurement in the follow-up of patients treated for differentiated thyroid cancer

Zucchelli G., Iervasi A., Ferdeghini M., Iervasi G.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):490-502

Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy

Molinaro E., Viola D., Passannanti P., Agate L., Lippi F., Ceccarelli C., Pinchera A., Elisei R.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):503-12

Diagnostic value of FDG PET/CT imaging

Pace L., Nicolai E., Klain M., Salvatore M.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):513-9

Redifferentiating agents in non-radioiodine avid cancer

Seregni E., Vellani C., Castellani M. R., Maccauro M., Pallotti F., Scaramellini G., Guzzo M., Greco A.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):520-5

Targeted therapy in radioiodine refractory thyroid cancer

Pacini F., Brilli L., Marchisotta S.


 REVIEWS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):526-35

Thyroid iatrogenic sequelae after the treatment of pediatric cancer

Massimino M., Gandola L., Seregni E., Bongarzone I., Morosi C., Collini P.


 ORIGINAL ARTICLES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):536-45

The effectiveness of 124I PET/CT in patients with differentiated thyroid cancer

Capoccetti F., Criscuoli B., Rossi G., Ferretti F., Manni C., Brianzoni E.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 Ottobre;53(5):546-61

Individualized dosimetry in the management of metastatic differentiated thyroid cancer

Chiesa C., Castellani M. R., Vellani C., Orunesu E., Negri A., Azzeroni R., Botta F., Maccauro M., Aliberti G., Seregni E., Lassmann M., Bombardieri E.


inizio pagina